Components of the metabolic syndrome and colorectal cancer risk; a prospective study - PubMed (original) (raw)
Components of the metabolic syndrome and colorectal cancer risk; a prospective study
T Stocks et al. Int J Obes (Lond). 2008 Feb.
Abstract
Objective: To examine the relation of well-known factors of the metabolic syndrome (MetS) as well as related circulating factors, with risk of colorectal cancer.
Methods: We performed a case control study of 306 colorectal cancer cases and 595 matched controls nested in the Northern Sweden Health and Disease Cohort. Levels of C-peptide, glycated haemoglobin (HbA1c), leptin and adiponectin were measured in cryopreserved samples. Body mass index (BMI), systolic and diastolic blood pressure and fasting and post-load plasma glucose, had been measured in a subcohort. Conditional logistic regression was used to calculate odds ratios (OR) of disease, including risk assessments for the MetS factors: obesity (BMI>30 kg m(-2)), hypertension (blood pressure > or =140/90 mmHg or use of anti-hypertensive drugs) and hyperglycaemia (fasting glucose > or =6.1 mmol l(-1) or post-load glucose in capillary plasma > or =8.9 mmol l(-1)).
Results: None of the studied variables were significantly associated with risk across quartiles. Presence of obesity, hypertension and hyperglycaemia significantly increased the risk of colorectal cancer; OR for three vs null factors was 2.57 (95% Confidence Interval [CI] 1.20-5.52; P (trend)=0.0021), as compared to a 30 to 70% increased risk for the factors in single. Similarly, top decile levels of C-peptide, HbA1c and leptin/adiponectin ratio were associated with an increased risk; ORs for top vs deciles 1-9 were 1.56 (95% CI 0.93-2.62; P=0.090), 1.83 (95% CI 1.00-3.36; P=0.051) and 1.50 (95% CI 0.83-2.71; P=0.18), respectively.
Conclusions: Our study support the view that components of the MetS increase risk of colorectal cancer, and further suggests that only very high levels of metabolic factors confer an increased risk.
Similar articles
- Insulin resistance is inversely related to prostate cancer: a prospective study in Northern Sweden.
Stocks T, Lukanova A, Rinaldi S, Biessy C, Dossus L, Lindahl B, Hallmans G, Kaaks R, Stattin P. Stocks T, et al. Int J Cancer. 2007 Jun 15;120(12):2678-86. doi: 10.1002/ijc.22587. Int J Cancer. 2007. PMID: 17278097 - Ramadan Intermittent Fasting Affects Adipokines and Leptin/Adiponectin Ratio in Type 2 Diabetes Mellitus and Their First-Degree Relatives.
Abdullah K, Al-Habori M, Al-Eryani E. Abdullah K, et al. Biomed Res Int. 2020 Jul 28;2020:1281792. doi: 10.1155/2020/1281792. eCollection 2020. Biomed Res Int. 2020. PMID: 32775407 Free PMC article. - Associations of the metabolic syndrome and its components with cognitive impairment in older adults.
Feinkohl I, Janke J, Hadzidiakos D, Slooter A, Winterer G, Spies C, Pischon T. Feinkohl I, et al. BMC Geriatr. 2019 Mar 7;19(1):77. doi: 10.1186/s12877-019-1073-7. BMC Geriatr. 2019. PMID: 30845934 Free PMC article. - Association between obesity-related adipokines and colorectal cancer: a case-control study and meta-analysis.
Joshi RK, Kim WJ, Lee SA. Joshi RK, et al. World J Gastroenterol. 2014 Jun 28;20(24):7941-9. doi: 10.3748/wjg.v20.i24.7941. World J Gastroenterol. 2014. PMID: 24976730 Free PMC article. Review. - Metabolic syndrome and the risk of colorectal cancer: a systematic review and meta-analysis.
Shen X, Wang Y, Zhao R, Wan Q, Wu Y, Zhao L, Wu X. Shen X, et al. Int J Colorectal Dis. 2021 Oct;36(10):2215-2225. doi: 10.1007/s00384-021-03974-y. Epub 2021 Jul 31. Int J Colorectal Dis. 2021. PMID: 34331119
Cited by
- Circulating adiponectin levels in various malignancies: an updated meta-analysis of 107 studies.
Wei T, Ye P, Peng X, Wu LL, Yu GY. Wei T, et al. Oncotarget. 2016 Jul 26;7(30):48671-48691. doi: 10.18632/oncotarget.8932. Oncotarget. 2016. PMID: 27119501 Free PMC article. Review. - Metabolic syndrome is a risk factor for colorectal adenoma and cancer: a study in a White population using the harmonized criteria.
Milano A, Bianco MA, Buri L, Cipolletta L, Grossi E, Rotondano G, Tessari F, Efthymakis K, Neri M. Milano A, et al. Therap Adv Gastroenterol. 2019 Sep 3;12:1756284819867839. doi: 10.1177/1756284819867839. eCollection 2019. Therap Adv Gastroenterol. 2019. PMID: 31523276 Free PMC article. - The two major epidemics of the twenty-first century: obesity and cancer.
Kaidar-Person O, Bar-Sela G, Person B. Kaidar-Person O, et al. Obes Surg. 2011 Nov;21(11):1792-7. doi: 10.1007/s11695-011-0490-2. Obes Surg. 2011. PMID: 21842287 Review. - Components of metabolic syndrome and metachronous colorectal neoplasia.
Ashbeck EL, Jacobs ET, MartÃnez ME, Gerner EW, Lance P, Thompson PA. Ashbeck EL, et al. Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1134-43. doi: 10.1158/1055-9965.EPI-08-1015. Epub 2009 Mar 24. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19318435 Free PMC article. Clinical Trial. - Study of intra-abdominal fat distribution in sigmoid colon cancer in Japanese patients by use of MDCT data.
Ogura T, Tachikawa T, Nishimura Y, Suda S, Shimomura Y, Oya M, Kono A. Ogura T, et al. Radiol Phys Technol. 2009 Jul;2(2):205-9. doi: 10.1007/s12194-009-0067-0. Epub 2009 Jul 1. Radiol Phys Technol. 2009. PMID: 20821121
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical